Latest News

At Tyson Eye, we’re committed to pushing the boundaries of what’s possible in eye care, especially when it comes to preserving vision in the face of challenging conditions like Dry Age-Related Macular Degeneration (Dry AMD). If you’ve followed our blog before, you already know we’ve introduced the Valeda Light Delivery System as a promising treatment option for patients with early

Age-related macular degeneration (AMD) is one of the leading causes of vision loss, affecting millions of people worldwide. While treatments for wet AMD exist, options for dry AMD have been limited—until now. The Valeda Light Delivery System offers a groundbreaking approach to managing dry AMD using photobiomodulation (PBM) therapy, providing patients with a non-invasive treatment that may help improve visual

Age-Related Macular Degeneration (AMD) is a leading cause of vision loss among older adults in the United States. This February, during AMD Awareness Month, Tyson Eye is committed to educating our community about this serious condition, its risk factors, and the importance of early detection. Did you know that 1 in 3 Americans over the age of 75 will develop

The retina is the light-sensitive tissue that lines the back of the eye. Made up of millions of photoreceptors (rods and cones), the retina interprets the light that comes in through the cornea and lens, then signals travel through the optic nerve and into the brain. And that is how you see. Vision can’t take place without the retina, and

The retina is the light-sensitive tissue that lines the back of the eye. Made up of millions of photoreceptors, the retina takes in the light that comes in through the cornea, and interprets that light into signals that travel through the optic nerve and into the brain. And that is how you see! Basically, vision can’t take place without the